Targovax Announces Publication of New Oncolytic Virus Data in the Journal of Medical Virology and Cancer Gene Therapy
- Wednesday, September 12, 2018, 0:12
- Environment
- Add a comment
OSLO, Norway, Sept. 12, 2018 /PRNewswire/ — Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, is pleased to note that pre-clinical data from its ONCOS oncolytic virus program has been published in two…
Source: https://www.prnewswire.com:443/news-releases/targovax-announces-publication-of-new-oncolytic-virus-data-in-the-journal-of-medical-virology-and-cancer-gene-therapy-300710957.html
About the Author
adminasapcorp has written 39026 stories on this site.